v3 Template
E

Esphera SynBio Inc

Biotechnology OTTAWA, ON, Canada ~105 employees
Founded
--
Employees (Est.)
~105
7 leaders known
Total Funding
$2.0M
Funding Rounds
1
Last Funding
2025-01-07

About Esphera SynBio Inc

Esphera SynBio is a company focused on synthetic biology for the treatment and prevention of disease. They aim to modify cells to produce therapeutic exosomes that can target specific conditions and deliver protein or RNA payloads.

Products & Services

Therapeutic Exosomes Platform:A technology platform for designing transgenes encoding multimeric proteins that traffic into budding exosomes, enabling the production of therapeutic exosomes in vivo with applications such as modifying tumor cells to create immunostimulatory cancer vaccines.

Specialties

Synthetic Biology Therapeutic Exosomes Cancer Vaccines Immunostimulatory Treatments

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 2000000
MR: -
FA: $2M USD
FAN: 2000000 		D: 2025-01-07
FD: 2025-01-07 		2 investors
Seed Latest
2025-01-07
$2.0M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Ted Danson

Host

B

Brian Lichty

Founder, CEO

LinkedIn (Pro only)
C

Carolina Ilkow

Founder, CSO

LinkedIn (Pro only)
J

John Bell

Founder, President

T

Trang Pham

Senior Scientist

J

Jake Nikota

Senior Scientist

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

Esphera SynBio Inc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~105 employees (est.)
Locations
OTTAWA, ON, Canada

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro